Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease

MicroRNAs (miRNAs) are extensively edited in human brains. However, the functional relevance of the miRNA editome is largely unknown in Parkinson’s disease (PD). By analyzing small RNA sequencing profiles of brain tissues of 43 PD patients and 88 normal controls, we found that the editing levels of...

Full description

Bibliographic Details
Main Authors: Chenyu Lu, Shuchao Ren, Wenping Xie, Zhigang Zhao, Xingwang Wu, Shiyong Guo, Angbaji Suo, Nan Zhou, Jun Yang, Shuai Wu, Yun Zheng
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/1/75
_version_ 1797626145712111616
author Chenyu Lu
Shuchao Ren
Wenping Xie
Zhigang Zhao
Xingwang Wu
Shiyong Guo
Angbaji Suo
Nan Zhou
Jun Yang
Shuai Wu
Yun Zheng
author_facet Chenyu Lu
Shuchao Ren
Wenping Xie
Zhigang Zhao
Xingwang Wu
Shiyong Guo
Angbaji Suo
Nan Zhou
Jun Yang
Shuai Wu
Yun Zheng
author_sort Chenyu Lu
collection DOAJ
description MicroRNAs (miRNAs) are extensively edited in human brains. However, the functional relevance of the miRNA editome is largely unknown in Parkinson’s disease (PD). By analyzing small RNA sequencing profiles of brain tissues of 43 PD patients and 88 normal controls, we found that the editing levels of five A-to-I and two C-to-U editing sites are significantly correlated with the ages of normal controls, which is disrupted in PD patients. We totally identified 362 miRNA editing sites with significantly different editing levels in prefrontal cortices of PD patients (PD-PC) compared to results of normal controls. We experimentally validated that A-to-I edited miR-497-5p, with significantly higher expression levels in PD-PC compared to normal controls, directly represses OPA1 and VAPB. Furthermore, overexpression of A-to-I edited miR-497-5p downregulates OPA1 and VAPB in two cell lines, and inhibits proliferation of glioma cells. These results suggest that the hyperediting of miR-497-5p in PD contributes to enhanced progressive neurodegeneration of PD patients. Our results provide new insights into the mechanistic understanding, novel diagnostics, and therapeutic clues of PD.
first_indexed 2024-03-11T10:06:20Z
format Article
id doaj.art-e16a1bf982ad42cca9051675f24ed960
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T10:06:20Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-e16a1bf982ad42cca9051675f24ed9602023-11-16T15:05:44ZengMDPI AGCells2073-44092022-12-011217510.3390/cells12010075Characterizing Relevant MicroRNA Editing Sites in Parkinson’s DiseaseChenyu Lu0Shuchao Ren1Wenping Xie2Zhigang Zhao3Xingwang Wu4Shiyong Guo5Angbaji Suo6Nan Zhou7Jun Yang8Shuai Wu9Yun Zheng10College of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaSchool of Criminal Investigation, Yunnan Police College, Kunming 650223, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaCollege of Landscape and Horticulture, Yunnan Agricultural University, Kunming 650201, ChinaMicroRNAs (miRNAs) are extensively edited in human brains. However, the functional relevance of the miRNA editome is largely unknown in Parkinson’s disease (PD). By analyzing small RNA sequencing profiles of brain tissues of 43 PD patients and 88 normal controls, we found that the editing levels of five A-to-I and two C-to-U editing sites are significantly correlated with the ages of normal controls, which is disrupted in PD patients. We totally identified 362 miRNA editing sites with significantly different editing levels in prefrontal cortices of PD patients (PD-PC) compared to results of normal controls. We experimentally validated that A-to-I edited miR-497-5p, with significantly higher expression levels in PD-PC compared to normal controls, directly represses OPA1 and VAPB. Furthermore, overexpression of A-to-I edited miR-497-5p downregulates OPA1 and VAPB in two cell lines, and inhibits proliferation of glioma cells. These results suggest that the hyperediting of miR-497-5p in PD contributes to enhanced progressive neurodegeneration of PD patients. Our results provide new insights into the mechanistic understanding, novel diagnostics, and therapeutic clues of PD.https://www.mdpi.com/2073-4409/12/1/75RNA editingParkinson’s diseasehsa-miR-497-5pOPA1VAPB
spellingShingle Chenyu Lu
Shuchao Ren
Wenping Xie
Zhigang Zhao
Xingwang Wu
Shiyong Guo
Angbaji Suo
Nan Zhou
Jun Yang
Shuai Wu
Yun Zheng
Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
Cells
RNA editing
Parkinson’s disease
hsa-miR-497-5p
OPA1
VAPB
title Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
title_full Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
title_fullStr Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
title_full_unstemmed Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
title_short Characterizing Relevant MicroRNA Editing Sites in Parkinson’s Disease
title_sort characterizing relevant microrna editing sites in parkinson s disease
topic RNA editing
Parkinson’s disease
hsa-miR-497-5p
OPA1
VAPB
url https://www.mdpi.com/2073-4409/12/1/75
work_keys_str_mv AT chenyulu characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT shuchaoren characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT wenpingxie characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT zhigangzhao characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT xingwangwu characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT shiyongguo characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT angbajisuo characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT nanzhou characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT junyang characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT shuaiwu characterizingrelevantmicrornaeditingsitesinparkinsonsdisease
AT yunzheng characterizingrelevantmicrornaeditingsitesinparkinsonsdisease